top of page
RhoGAM’s Role in Pregnancy: Facts & Controversies with Dr. Matt Reeves, Dr. Amy Park on the BackTable OBGYN Podcast
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable OBGYN

Episode # 45  •  23 Jan 2024

RhoGAM’s Role in Pregnancy: Facts & Controversies

This episode of BackTable OBGYN features Dr. Matt Reeves, a seasoned OBGYN and CEO/Founder of the DuPont Clinic, and host Dr. Amy Park as they discuss the use of Rh immune globulin (RhoGAM) in pregnancy.

Timestamps

00:00 - Introduction
03:09 - Understanding RhoGAM: Origin and Development
06:06 - The Science Behind RhoGAM and Its Role in Pregnancy
08:13 - The Controversy and Debate Around RhoGAM Usage
11:52 - The Impact of RhoGAM on Public Health and Medical Practice
15:25 - The Future of RhoGAM: Perspectives and Predictions
29:24 - Closing Thoughts and Further Resources

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

RhoGAM is traditionally administered to Rh- women at 28 weeks gestation, within 72 hours of birth, and frequently after an abortion in order to prevent Rhesus alloimmunization in future pregnancies. However, with recent data showing negligible Rh- blood cell exposure in early pregnancy terminations, the need for RhoGAM in such cases is being questioned. Additionally, considering the scarcity of RhoGAM and the reality of smaller family sizes globally, the importance of RhoGAM in Rh alloimmunization prevention might not be as significant as previously thought. However, limited evidence and ingrained medical practices may cause the transition to be slow.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page